139 related articles for article (PubMed ID: 20130026)
1. In vitro interaction of posaconazole with calcineurin inhibitors and sirolimus against zygomycetes.
Narreddy S; Manavathu E; Chandrasekar PH; Alangaden GJ; Revankar SG
J Antimicrob Chemother; 2010 Apr; 65(4):701-3. PubMed ID: 20130026
[TBL] [Abstract][Full Text] [Related]
2. In vitro interaction of caspofungin and immunosuppressives against agents of mucormycosis.
Thakur M; Revankar SG
J Antimicrob Chemother; 2011 Oct; 66(10):2312-4. PubMed ID: 21795260
[TBL] [Abstract][Full Text] [Related]
3. In vitro interactions between isavuconazole and tacrolimus, cyclosporin A or sirolimus against Mucorales.
Schwarz P; Schwarz PV; Felske-Zech H; Dannaoui E
J Antimicrob Chemother; 2019 Jul; 74(7):1921-1927. PubMed ID: 30934052
[TBL] [Abstract][Full Text] [Related]
4. In vitro interactions between antifungals and immunosuppressive drugs against zygomycetes.
Dannaoui E; Schwarz P; Lortholary O
Antimicrob Agents Chemother; 2009 Aug; 53(8):3549-51. PubMed ID: 19451295
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of miltefosine as a single agent and in combination with voriconazole or posaconazole against uncommon filamentous fungal pathogens.
Biswas C; Sorrell TC; Djordjevic JT; Zuo X; Jolliffe KA; Chen SC
J Antimicrob Chemother; 2013 Dec; 68(12):2842-6. PubMed ID: 23861311
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo activities of posaconazole against zygomycetes with various degrees of susceptibility.
Spreghini E; Orlando F; Giannini D; Barchiesi F
J Antimicrob Chemother; 2010 Oct; 65(10):2158-63. PubMed ID: 20667887
[TBL] [Abstract][Full Text] [Related]
7. Multicenter evaluation of MIC distributions for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of Mucorales.
Espinel-Ingroff A; Chakrabarti A; Chowdhary A; Cordoba S; Dannaoui E; Dufresne P; Fothergill A; Ghannoum M; Gonzalez GM; Guarro J; Kidd S; Lass-Flörl C; Meis JF; Pelaez T; Tortorano AM; Turnidge J
Antimicrob Agents Chemother; 2015 Mar; 59(3):1745-50. PubMed ID: 25583714
[TBL] [Abstract][Full Text] [Related]
8. In vitro antifungal susceptibility of filamentous fungi causing rare infections: synergy testing of amphotericin B, posaconazole and anidulafungin in pairs.
Drogari-Apiranthitou M; Mantopoulou FD; Skiada A; Kanioura L; Grammatikou M; Vrioni G; Mitroussia-Ziouva A; Tsakris A; Petrikkos G
J Antimicrob Chemother; 2012 Aug; 67(8):1937-40. PubMed ID: 22535624
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Activity of Isavuconazole and Comparators against Clinical Isolates of the Mucorales Order.
Arendrup MC; Jensen RH; Meletiadis J
Antimicrob Agents Chemother; 2015 Dec; 59(12):7735-42. PubMed ID: 26438494
[TBL] [Abstract][Full Text] [Related]
10. Interaction of amphotericin B lipid formulations and triazoles with human polymorphonuclear leucocytes for antifungal activity against Zygomycetes.
Simitsopoulou M; Roilides E; Maloukou A; Gil-Lamaignere C; Walsh TJ
Mycoses; 2008 Mar; 51(2):147-54. PubMed ID: 18254752
[TBL] [Abstract][Full Text] [Related]
11. The calcineurin pathway inhibitor tacrolimus enhances the in vitro activity of azoles against Mucorales via apoptosis.
Shirazi F; Kontoyiannis DP
Eukaryot Cell; 2013 Sep; 12(9):1225-34. PubMed ID: 23851337
[TBL] [Abstract][Full Text] [Related]
12. Stress response in medically important Mucorales.
Singh P; Paul S; Shivaprakash MR; Chakrabarti A; Ghosh AK
Mycoses; 2016 Oct; 59(10):628-35. PubMed ID: 27292160
[TBL] [Abstract][Full Text] [Related]
13. Activity of posaconazole and other antifungal agents against Mucorales strains identified by sequencing of internal transcribed spacers.
Alastruey-Izquierdo A; Castelli MV; Cuesta I; Monzon A; Cuenca-Estrella M; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 2009 Apr; 53(4):1686-9. PubMed ID: 19171801
[TBL] [Abstract][Full Text] [Related]
14. Effect of media composition and in vitro activity of posaconazole, caspofungin and voriconazole against zygomycetes.
Gil-Lamaignere C; Hess R; Salvenmoser S; Heyn K; Kappe R; Müller FM
J Antimicrob Chemother; 2005 Jun; 55(6):1016-9. PubMed ID: 15883179
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibility of 15 strains of zygomycetes to nine antifungal agents as determined by the NCCLS M38-A microdilution method.
Singh J; Rimek D; Kappe R
Mycoses; 2005 Jul; 48(4):246-50. PubMed ID: 15982206
[TBL] [Abstract][Full Text] [Related]
16. Sterol Composition of Clinically Relevant Mucorales and Changes Resulting from Posaconazole Treatment.
Müller C; Neugebauer T; Zill P; Lass-Flörl C; Bracher F; Binder U
Molecules; 2018 May; 23(5):. PubMed ID: 29783739
[TBL] [Abstract][Full Text] [Related]
17. Cunninghamella bertholletiae exhibits increased resistance to human neutrophils with or without antifungal agents as compared to Rhizopus spp.
Simitsopoulou M; Georgiadou E; Walsh TJ; Roilides E
Med Mycol; 2010 Aug; 48(5):720-4. PubMed ID: 20100138
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the fungicidal activity of amphotericin B and posaconazole against Zygomycetes in vitro.
Krishnan-Natesan S; Manavathu EK; Alangaden GJ; Chandrasekar PH
Diagn Microbiol Infect Dis; 2009 Apr; 63(4):361-4. PubMed ID: 19302924
[TBL] [Abstract][Full Text] [Related]
19. Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole.
Chamilos G; Lewis RE; Kontoyiannis DP
Antimicrob Agents Chemother; 2006 Jan; 50(1):96-103. PubMed ID: 16377673
[TBL] [Abstract][Full Text] [Related]
20. Posaconazole enhances the activity of amphotericin B against hyphae of zygomycetes in vitro.
Perkhofer S; Locher M; Cuenca-Estrella M; Rüchel R; Würzner R; Dierich MP; Lass-Flörl C
Antimicrob Agents Chemother; 2008 Jul; 52(7):2636-8. PubMed ID: 18458135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
